www.ila-lead.org

Industry Exposure Trends and Voluntary Industry Exposure Trends and Voluntary

Blood Lead Reduction Programs Blood Lead Reduction Programs European Lead IndustryEuropean Lead Industry

Aggie Kotze

REACH Manager

International Lead Association - Europe

www.ila-lead.org

ILA-Europe Blood Pb collectionILA-Europe Blood Pb collectionBackgroundBackground

• Blood lead data has been collected for the purposes of the:

• Voluntary risk assessment Voluntary risk assessment (1998-2001)

• REACHREACH (2008-2010, updated 2013)

• Data collected from manufacturers but also

Downstream users sectors

• For REACH purposes

– Companies provided individualindividual worker (not aggregated or averaged) blood lead data via a questionnaire

– Data collected on anonymous basisData collected on anonymous basis

– Statistical analysis undertaken by ILA

www.ila-lead.org

ILA-Europe Blood Pb collectionILA-Europe Blood Pb collectionBackgroundBackground

• Purpose of blood lead data collection exercisePurpose of blood lead data collection exercise– To show European authorities that industry is industry is

continually improving continually improving in managing lead exposure in the workplace by adopting effective risk management measures

– To demonstrate for each use that the 9090thth percentile percentile of exposure data is below the DNEL of 40 µg/dLof exposure data is below the DNEL of 40 µg/dL and thus demonstrate risk is controlledrisk is controlled

Derived no-effect level (DNEL): is the level of exposure Derived no-effect level (DNEL): is the level of exposure to a substance above which humans to a substance above which humans should not be should not be exposed.exposed.

Derived no-effect level (DNEL): is the level of exposure Derived no-effect level (DNEL): is the level of exposure to a substance above which humans to a substance above which humans should not be should not be exposed.exposed.

www.ila-lead.org

ILA-Europe Blood Pb collectionILA-Europe Blood Pb collectionBackgroundBackground

• 2010 REACH registration dossier - 2010 REACH registration dossier - reported reported distributions for blood lead data distributions for blood lead data at the 7575thth percentile percentile to demonstrate exposures BELOW the DNEL to demonstrate exposures BELOW the DNEL for the period 2005-2007.

• 2013 REACH registration dossier update - 2013 REACH registration dossier update - blood lead data reported for companies adopting agreed RMM at the 9090thth percentile percentile for the exposure period 2009-2012 (requested by ECHA)

9090thth percentile – percentile – considered considered worst case worst case of of exposure under REACHexposure under REACH

9090thth percentile – percentile – considered considered worst case worst case of of exposure under REACHexposure under REACH

www.ila-lead.org

Year

REACH blood lead data (90REACH blood lead data (90thth percentile) percentile)

www.ila-lead.org

Sector Blood Lead DataSector Blood Lead DataSector Blood Lead DataSector Blood Lead Data

www.ila-lead.org

Primary Lead ProducersPrimary Lead Producers

Data for 8 legal Data for 8 legal entities (2009-entities (2009-

2012)2012)

www.ila-lead.org

Secondary Lead ProducersSecondary Lead Producers

www.ila-lead.org

Lead Oxide & Stabiliser ProducersLead Oxide & Stabiliser Producers

www.ila-lead.org

Lead Sheet ProducersLead Sheet Producers

www.ila-lead.org

– Good response from companies on blood lead data collection

– Robust and representative dataset available for all EU sectors

– Data demonstrates adequate control for all sectors if Companies adopt risk management measures specified in REACH Chemical Safety Reports (RCR <1)

– Sector REACH compliance is however dependant on performance of individual companies as assessed against worst 10% of data

– Companies are encouraged to continuously reduce blood lead levels of employees

Key messagesKey messages